Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors (PROMID): results of long-term survival - Rinke, A; Wittenberg, M; Schade-Brittinger, C (Neuroendocrinology, 2017)
, et al; PROMID Study Group.